The largest database of trusted experimental protocols

Trypsin ethylenediaminetetraacetic acid edta solution

Manufactured by Merck Group
Sourced in United States, Germany

Trypsin–ethylenediaminetetraacetic acid (EDTA) solution is a laboratory reagent used for cell detachment and dissociation. It contains the enzyme trypsin and the chelating agent EDTA, which work together to disrupt cell-cell and cell-substrate adhesions, allowing cells to be harvested from cell culture vessels.

Automatically generated - may contain errors

14 protocols using trypsin ethylenediaminetetraacetic acid edta solution

1

Culturing Human Transformed RPE Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
D407 cells, a human spontaneously transformed RPE cell line [46 ], were kindly provided by Dr. Jean Bennett (University of Pennsylvania, Philadelphia, PA, USA). Cells were maintained in 5% CO2–95% air at 37 °C and grown in Dulbecco’s Modified Eagle Medium (DMEM) with 5.5 mM D-glucose (Sigma-Aldrich, St. Louis, MO, USA) supplemented with 1% penicillin/streptomycin (Sigma-Aldrich, St. Louis, MO, USA), 1% glutamine (Sigma-Aldrich, St. Louis, MO, USA), and 5% fetal bovine serum (FBS, Sigma-Aldrich, St. Louis, MO, USA). For sub-culturing, cells were dissociated with a trypsin-Ethylenediaminetetraacetic Acid (EDTA) solution (Sigma-Aldrich, St. Louis, MO, USA), split 1:5 and cultured in 21 cm2 culture flasks (Orange Scientific, Braine-lÁlleud, Belgium). Culture medium was changed every 2 days.
+ Open protocol
+ Expand
2

Culturing Human Colorectal Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human colorectal cancer cell lines (HCT116, Caco-2/TC-7, and HT29) and normal colon cell lines (CCD18Co and NCM-460) will be purchased from American Type Culture Collection. For cell culturing, RPMI 1640 (Sigma-Aldrich) medium will be used, supplemented with 10% fetal bovine serum (Sigma-Aldrich) and 1% penicillin/streptomycin antibiotic cocktail (Sigma-Aldrich). The culture flasks (T25/T75) will be incubated in a 5% CO2 humidified incubator at 37 ºC. After reaching 70% to 80% confluency, the cells will be split using 1% trypsin–ethylenediaminetetraacetic acid (EDTA) solution (Sigma-Aldrich).
+ Open protocol
+ Expand
3

Bioactivity Screening of Natural Compounds

Check if the same lab product or an alternative is used in the 5 most similar protocols
Phosphatidylcholine (egg yolk), 2,2-diphenyl-1-picrylhydrazyl (DPPH), Folin–Ciocalteu reagent, sodium cholate, sodium carbonate, Triton X-100, a mixture of penicillin, neomycin, streptomycin dissolved in 0.9% NaCl (PSN), L-ascorbic acid, hydrogen peroxide 30% (w/w) (H2O2), PBS, fetal equine serum (FES), Eagle’s minimum essential medium (EMEM), and 0.25% trypsin-ethylene-diamine-tetraacetic-acid (EDTA) solution were acquired from Sigma-Aldrich (Darmstadt, Germany). High-performance liquid chromatography (HPLC) standards, catechin hydrate, (-)epicatechin, rutin hydrate, kaempferol, myricetin, quercetin, and trans-resveratrol, as well as caffeic, chlorogenic, p-coumaric, gallic, rosmarinic, protocatechuic, caftaric, vanillic, syringic, trans-ferulic, ellagic dihydrate, and chicoric acids, were acquired from Sigma-Aldrich (Darmstadt, Germany). Rhodamine B from Sigma-Aldrich (Darmstadt, Germany), WGA-AlexaFluor 488 conjugate from Thermo Fischer (Waltham, Massachusetts State or Province, US), and Hoechst 33342 from Molecular Probes (Eugene, Oregon, US) were used as fluorophores. The murine fibroblast cell line (L-929) was obtained from ATCC®CRL-6364™ (Manassas, Virginia, US) and the CellTiter96®aqueous non-radioactive cell proliferation assay was purchased from Promega (Madison, WI, USA).
+ Open protocol
+ Expand
4

Inflammatory Response of Vascular Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human fibrinogen and BAY 11-7082 ((E)3-[(4-Methylphenyl)sulfonyl]-2- propenenitrile) were purchased from Calbiochem (La Jolla, CA, USA); Ham's F12K medium was from Gibco-Invitrogen (Carlsbad, CA, USA). Collagen type I, fetal bovine serum and trypsin/ethylenediaminetetraacetic acid (EDTA) solution were obtained from Sigma-Aldrich (Saint Louis, MO, USA). Recombinant TNF-α and ELISAs for interleukin-8 (IL-8), interleukin-1β (IL-1β) and Platelet Factor 4 (PF4) determination were from R&D Systems (Minneapolis, MN, USA). ACD Vacutainers® were used for blood collection (BD Brasil, Sao Paulo, Brazil). All other products were from Sigma-Aldrich unless otherwise stated.
+ Open protocol
+ Expand
5

Collagen-Based Cell Culture Protocols

Check if the same lab product or an alternative is used in the 5 most similar protocols
Chemicals and reagents were purchased from
commercial sources at the highest purity available and used without
further purification. All solvents were purchased from Sigma-Aldrich
unless stated otherwise. Cellnest, a recombinant peptide based on
human collagen type I (RCPhC1), was a gift from Fujifilm Manufacturing
Europe B.V. and was used without further purification (Figure S1). Phosphate buffered saline (PBS) tablets
were purchased from Sigma-Aldrich (pH 7.2–7.6). Trypsin–ethylenediaminetetraacetic
acid (EDTA) solution was purchased from Sigma (0.5 g/L porcine trypsin
and 0.2 g/L EDTA in Hank’s balanced salt solution with phenol
red). All compound concentrations were determined by weight.
+ Open protocol
+ Expand
6

Cultivation and Characterization of Breast Cancer Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
The human breast adenocarcinoma cell lines MCF-7 and MDA-MB-231 were obtained from the European Collection of Cell Cultures (ECCC, Salisbury, UK). These cell lines were grown in 100-mm Petri dishes in Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 10% fetal bovine serum (FBS), 100 U/ml penicillin, and 100 μg/ml streptomycin in an air-CO2 (95:5) atmosphere at 37°C. Confluent cells were washed twice with phosphate-buffered saline (PBS) and harvested by a brief incubation with trypsin- ethylenediaminetetraacetic acid (EDTA) solution (Sigma-Aldrich, St. Louis, MO, USA). Geneticin (G418), culture medium, and sera were purchased from Invitrogen Life Technologies, Carlsbad, CA, USA. Immobilon-P membranes were from Millipore (Merck Millipore, Billerica, MA, USA). Mytomycin C, MTT, puromycin, and hygromycin B were from Sigma-Aldrich.
+ Open protocol
+ Expand
7

Generation of Neuroblastoma Cell Line Overexpressing α-Synuclein

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human neuroblastoma SH-SY5Y cells were purchased from ATCC (Manassas, VA, USA) and maintained at 37 °C in a humidified atmosphere supplied with 5% CO2 in a Dulbecco’s Modified Eagle Medium (DMEM):Ham’s F12 medium (1:1) (Gibco®, Life Technologies, Carlsbad, Canada) supplemented with 10% Fetal Bovine Serum (FBS), 2 mM L-glutamine, and 100 U/mL penicillin and 100 g/mL streptomycin (Lonza, Basel, Switzerland). Cell harvesting was performed using a Trypsin/Ethylenediaminetetraacetic acid (EDTA) solution (Sigma-Aldrich, Steinheim, Germany).
The cells were seeded in 60 mm dishes (1.5 × 106 cells/dish) and transfected with pHM6-αSyn-wt (#40824, AddGene, Cambridge, MA) or pHM6-Mock using a K2® Transfection System (Biontex Laboratories GmbH, München, Germany) to generate SH-SY5Y stably overexpressing αSyn (SH-Syn) or control cells (SH-Mock), respectively. G418 at 800 μg/mL (Sigma-Aldrich, Steinheim, Germany) was added to the culture medium 48 h after transfection for transfected cell selection; then, the cells were maintained in a culture medium supplemented with G418 at 200 μg/mL.
Cell morphology phase-contrast images were acquired via an inverted microscope Zeiss Axiovert 200 (Carl Zeiss, Gottingen, Germany) equipped with a color digital camera Axiocam MR (Carl Zeiss, Gottingen, Germany) using the Axiovision 4.8 program (Vysis, Downers Grove, IL, USA).
+ Open protocol
+ Expand
8

Radioisotope-based Cell Proliferation Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
ASP (Sigma, St. Louis, MO, USA); MET (European Pharmacopeia, Strasbourg, France); 3H-Deoxy-D-glucose (2-[1,2-3H(N)]-deoxy-D-glucose: specific activity 60 Ci/mmol); 14C-n-butyric acid ([1-14C-n-butyric acid]; specific activity 55 mCi/mmol) (American Radiolabeled Chemicals Inc., St Louis, MO, USA); 3H-thymidine ([methyl-3H]-thymidine; specific activity 79 Ci/mmol) (GE Healthcare GmbH, Freiburg, Germany); trypsin-EDTA 0.25% (PAN-Biotech™, Aidenbach, Germany); crystal violet, triton X-100, trichloroacetic acid (TCA) (Merck, Darmstadt, Germany); Dulbecco’s Modified Eagle Medium (DMEM; catalogue #D5796), Minimum Essential Medium (MEM; catalogue #M-0643), antibiotic/antimycotic solution (100 U/mL penicillin, 0.1 mg/mL streptomycin, and 0.25 µg/mL amphotericin B), bovine serum albumin (BSA), fetal bovine serum (FBS), reduced nicotinamide adenine dinucleotide (NADH), resazurin, hydroxyethylpiperazine-N0-2-ethanesulfonic acid (HEPES), sodium pyruvate; sulforhodamine B (SRB), tris-HCl (tris(hydroxymethyl)-aminomethane hydrochloride), trypsin–ethylenediaminetetraacetic acid (EDTA) solution (Sigma, St. Louis, MO, USA).
+ Open protocol
+ Expand
9

HIV-1 Entry Assay with TZM-bl and PBMC

Check if the same lab product or an alternative is used in the 5 most similar protocols
TZM-bl cells were obtained from the NIH AIDS Research and Reference Reagent Program (Cat. no. 8129). This cell line is derived from a clone of HeLa cells designed for expressing HIV-1 virus entry receptor and co-receptors (CD4, CXCR4, and CCR5) with an integrated luciferase gene under the control of the HIV-1 promoter long terminal repeat (LTR) [16 (link),17 (link)], which makes it possible to measure infection. HEK293T cells were purchased from the American Tissue Culture Collection (ATCC). TZM-bl and HEK293T cells were cultured at 37 °C with 5% CO2 in DMEM supplemented with heat-inactivated fetal bovine serum (FBS) (Sigma-Aldrich, St. Louis, MO, USA). Cell monolayers were detached via treatment with a Trypsin ethylenediaminetetraacetic acid (EDTA) solution of 0.25% (Sigma-Aldrich, St. Louis, MO, USA).
H9/HTLV-IIIB cells (ATCC-CRL-8543) were persistently infected and were used to produce HIV-1IIIB (X4-tropic HIV-1) viral stocks. Human peripheral blood mononuclear cells (PBMC) from two healthy donors were obtained from the blood bank of the Hospital Universitario San Vicente Fundación. PBMC were isolated through a density gradient with Ficoll-Histopaque (Sigma-Aldrich, St. Louis, MO, USA). H9/HTLV-IIIB and PBMC were maintained in RPMI-1640 medium (Sigma-Aldrich, St. Louis, MO, USA), supplemented with 10% heat-inactivated FBS incubated in a humid atmosphere with 5% CO2 at 37 °C.
+ Open protocol
+ Expand
10

Cell Culture and Characterization of NOK-si and FGH

Check if the same lab product or an alternative is used in the 5 most similar protocols
NOK-si (kindly provided by Professor Carlos Rossa Jr., from the Cellular and Molecular Biology Laboratory, Department of Periodontics, School of Dentistry, São Paulo State University—UNESP) and FGH (Rio de Janeiro Cell Bank; code: 0089) cells were thawed and cultured in Eagle medium modified by Dulbecco high glucose (DMEM) (4.5 g/L), supplemented with 2.0 mmol·L−1 of glutamine (Lonza, Basel, Switzerlnad, 10% of bovine serum), 1% antibiotic/antimycotic (penicillin G—10,000 μg·mL−1, streptomycin—10,000 μg·mL−1, amphotericin B—25 μg·mL−1) (Sigma-Aldrich, St. Louis, MO, USA) incubated with 5% CO2 in the atmosphere and cultured until reaching 80% confluence. The cells were washed (PBS buffer; pH 7.2), detached from the plate with a 0.05% trypsin ethylenediaminetetraacetic acid (EDTA) solution (Sigma-Aldrich, St. Louis, MO, USA), and then the cells were counted. In the experiments, 2.5 × 105 cells/well were used for NOK-si and 1.2 × 105 cells/well were used for FGH. For all experiments, cells between the 3rd and 8th passages were used [28 (link)].
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!